Skip to main content

Institutional filer profile

ARCH Venture Partners IX LLC Insider Trades

ARCH Venture Partners IX LLC has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $24,960,152 across 2 companies. The most recent open-market transaction was reported on Nov 4, 2026. Source: SEC Form 4 filings.

Latest reported as Corporate insider of Lyell Immunopharma, Inc. (LYEL).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
1
Reported companies
2
Net open-market value
$24,960,152
Latest transaction
Nov 4, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 4, 2026Lyell Immunopharma, Inc. (LYEL)Corporate insiderOpen Market Purchase2,321,262$10.77$24,999,992
Jul 1, 2026Boundless Bio, Inc. (BOLD)Corporate insiderSale16,000$2.49$39,840

Common questions

ARCH Venture Partners IX LLC insider trading FAQ

Is ARCH Venture Partners IX LLC buying or selling stock?
Across all SEC Form 4 open-market filings on record, ARCH Venture Partners IX LLC is a net buyer of $24,960,152, with 1 open-market purchase reported. The latest transaction was reported on Nov 4, 2026.
Which companies does ARCH Venture Partners IX LLC report insider trades for?
ARCH Venture Partners IX LLC has reported open-market trades in Lyell Immunopharma, Inc. (LYEL), Boundless Bio, Inc. (BOLD). The latest SEC-reported relationship is Corporate insider of Lyell Immunopharma, Inc. (LYEL).
Where does ARCH Venture Partners IX LLC's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under filer CIK 1723174, and refreshes this page daily.